ArisGlobal's COVID-19 Response

Our entire team is ready to continue servicing all customers without interruption, committing to providing exceptional support and customer satisfaction, even in times of uncertainty.

India's Largest Biotech Selects LifeSphere eTMF

The largest biopharmaceutical company in India that enables access to high quality, advanced therapies for chronic diseases, has selected LifeSphere® eTMF as its electronic trial master file system.

Luye Pharma Selects LifeSphere® Signal and Risk Management

Luye Pharma, a pharmaceutical company dedicated to the R&D, manufacturing, and sale of innovative medications, has selected LifeSphere as its next-generation signal detection tool.


How to Manage BREXIT Changes with LifeSphere RIMS

BREXIT, the withdrawal of the United Kingdom (UK) from the European Union (EU) and the European Atomic Energy Community (EAEC or Euratom), has changed the way business is done in a wide variety of industries. Since the pharmaceutical industry is the third largest...

read more

How Medical Affairs is Becoming a Strategic Pillar in Pharma

How Medical Affairs is Becoming a Strategic Pillar in Pharma Science and data are transforming the groundwork for pharma for both patients and customers and innovation is altering the healthcare landscape. These developments are expanding commercial opportunities...

read more

Journey to IDMP and Beyond

Regulatory teams serve as a gateway between life science organizations, the health authorities, and the market. In the past several years, great strides have been made to make regulatory teams smarter and more efficient. The journey to IDMP is something that aligns...

read more

Balancing Speed, Safety, and Risks in a Global Pandemic

In the age of Covid-19, the cause of a global pandemic, everything has changed over the last year in nearly every aspect of life. The pharmaceutical industry is at the center of this on helping to mitigate. We have seen dramatic adjustments in the way vaccines are...

read more

Letter From Our CEO: Nordic Capital Acquires ArisGlobal, Fuels Growth

It is with great excitement that we announce that Nordic Capital has entered into a definitive agreement to acquire ArisGlobal. Over these 32 years, ArisGlobal has built a sustainable and growing business that thrives on its partnerships with many life sciences companies and regulatory agencies. These customer relationships, some lasting decades, have allowed ArisGlobal to become a leading healthcare technology company with over 1200 employees across an expansive global footprint.

read more